hiv drug resistance database stanford university hiv drug resistance database a curated public database designed to represent store and analyze the divergent forms of data underlying hiv drug resistance home genotype rx genotype pheno genotype clinical hiv db program ini resistance mutations and response to new ini containing regimens there has been only one salvage therapy study in which raltegravir ral experienced patients were treated with a second ini dolutegravir dtg this phase ii study has two cohorts receiving two different dtg doses dolutegavir dtg reference previous ini follow up ini other rx no pts wk effect of baseline mutations on response eron 2010 viking trial cohort 1 100 ral dtg obt 27 2 in 18 subjects with viruses having mutations belonging to n155h or y143 pathways the mean plasma hiv 1 rna decrease by day 11 was 1.8 log copies ml 3 5 subjects with q148h g140s had an rna decrease of 0.7 logs by day 11 none of 4 subjects with q148 mutation plus 2 additional mutations at positions 74 138 and 140 had an rna decrease 0.7 logs abbreviations ral raltegravir dtg dolutegravir formerly gsk9572 ob optimized background w week m month references database citing database terms of use faqs user guide & database documents database statistics news resources hiv treatment websites rt protease and integrase structures additional resources team who we are & how to contact us publications acknowledgements 1998 2012 all rights reserved questions contact hivdb
